Borocaptate Disodium is a boron-containing compound classified as a boron delivery agent primarily utilized in boron neutron capture therapy (BNCT). This treatment modality targets malignant tissues by… Read more
Borocaptate Disodium is a boron-containing compound classified as a boron delivery agent primarily utilized in boron neutron capture therapy (BNCT). This treatment modality targets malignant tissues by accumulating the drug within tumor cells, which are then irradiated to induce cell death through the targeted destruction of cellular DNA and structures. To support rigorous quality control and analytical validation, this category offers a comprehensive range of reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting impurity profiling, method development, and quantitative analysis. By providing high-quality reference materials, researchers can accurately monitor the synthesis and degradation of this specialized compound, ensuring compliance with regulatory standards throughout the development and manufacturing process of boron-based therapeutic agents.